DANCANN PHARMA A/S

DANCANN PHARMA A/S (CVR number: 39426005K) is a company from VARDE. The company reported a net sales of 5.7 mDKK in 2022, demonstrating a growth of 553.1 % compared to the previous year. The operating profit percentage was poor at -287.6 % (EBIT: -16.4 mDKK), while net earnings were -16.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was -21.3 %, which can be considered poor and Return on Equity (ROE) was -27.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 85.2 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. DANCANN PHARMA A/S's liquidity measured by quick ratio was 1.5 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.